News

Filter

Current filters:

Tibotec

1 to 9 of 10 results

Gilead in another licensing deal with J&J unit for combo HIV/AIDS treatment

16-11-2011

US biotech firm Gilead Sciences (Nasdaq: GILD) has entered into a license agreement with Tibotec Pharmaceuticals,…

Anti-viralsBiotechnologycobicistatEmtrivaGilead SciencesJohnson & JohnsonLicensingPharmaceuticalPrezistaResearchTibotec

Gilead to develop combo cobicistat and Prezista AIDS drug with J&J unit Tibotec

29-06-2011

US biotech firm Gilead Sciences (Nasdaq: GILD) has entered into a license agreement with Tibotec Pharmaceuticals,…

Anti-viralsBiotechnologycobicistatEmtrivaGilead SciencesJohnson & JohnsonLicensingPharmaceuticalPrezistaResearchTibotec

Gilead Sciences files NDA for once-daily Truvada and TMC278 tablet for HIV

24-11-2010

Gilead Sciences (Nasdaq: GILD) yesterday submitted a New Drug Application to the US Food and Drug Administration…

Anti-viralsGilead SciencesJohnson & JohnsonNorth AmericaPharmaceuticalRegulationTibotecTruvada

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top